You are here

Strategy and Competition in Pharmaceuticals and Biotechnology

Spring 2010 MBA Course

B8799-017: Strategy and Competition in Pharmaceuticals and Biotechnology

MW - B Term, 12:30PM to 02:00PM
Location: URI 332

This course examines the strategic, technological, competitive, organizational, and political challenges impacting the pharmaceutical and biotechnology industry. Its perspective is global, including developed markets (U.S., EU, Japan) and emerging markets. Critical issues to be examined include:
•    Strategies and process of discovering, developing, and the  approval of new drugs and biologics;
•    Impact of government oversight and regulation;
•    Patents on pharmaceuticals and biologics;
•    Franchise/ R&D portfolio management;
•    Drug pricing and third-party reimbursement;
•    Pharmaceutical supply chain; design of prescription drug plans; PBMs/contracting;
•    Rx product life cycle management;
•    Int’l/ emerging markets – business strategies and growth prospects;
•    Vaccines – development, regulatory, pricing, distribution;
•    Health policy matters impacting this sector;
•    M&A in the biopharmaceutical sector.

The course is cross-functional in its approach, focuses on “real-world” problems currently facing senior managers in this sector, and identifies emerging trends that will materially impact future performance of “Big Pharma” companies, as well as “small-cap” specialty pharmaceutical and biotechnology firms. This course will be useful for students interested in careers in pharmaceuticals, biotechnology, and health services, as well as management consulting, investment banking, equity research, venture capital, private equity, insurance, and investment management given the large and growing healthcare/ pharmaceutical practices of such firms. Some understanding and prior experience in the healthcare/pharma industry will be highly useful.
Evaluation is 25% class participation, 25% mid-term assignment (questions or case study), and 50% final paper (questions or case study).